Meet with BIOVECTRA at the mRNA-Based Therapeutics Summit 2024!
Boston, MA | July 29-31, 2024

Schedule a meeting with us at this year's mRNA-Based Therapeutics Summit and discover how BIOVECTRA can help with your mRNA manufacturing needs.

BIOVECTRA's state-of-the-art Biomanufacturing and Vaccine Center has the:

• Capability to develop and manufacture plasmid DNA, mRNA, LNP formulations and fill finish
• With scales ranging from mL to 30L, we have the ability to produce up to 160 million doses of mRNA vaccines per year
• Capacity to prepare and package 70 million fill/finish doses per year for commercial distribution

At BIOVECTRA we specialize in clinical-to-commercial scale production capabilities for:

• Synthetic small molecules 
• Custom Lipids
• Fermented small molecules
• pDNA/mRNA/LNP
• Highly potent APIs
• Biologics 
• Bioreagents

 

Schedule a meeting with us and discover how we can support your  projects and solve your most complex challenges.

 

---

Stay connected with us